Antti Kotimaa is a seasoned professional with extensive experience in research and development, innovation, and business advisory roles. Currently serving as an RDI Advisor at Savonia University of Applied Sciences since December 2016, Kotimaa also founded Sonai Health Oy in June 2021. As Chairman and Board Member of Savon Luppo ry since January 2002, Kotimaa has played a significant leadership role. Previous positions include Development Manager at SPARK Finland and Innovation Advisor at Neurocenter Finland, both enhancing collaboration between companies and researchers. Kotimaa's academic background includes a PhD in Molecular Biology and an MSc in Biotechnology from the University of Eastern Finland, complemented by research experience in vascular biology and biotechnological applications.